Phase 3 Premature infants Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Active
Phase 3
Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on Outcome (TORPIDO 30/60)
Premature infants requiring resuscitation at birth
University of Sydney1,470 enrolled13 locationsACTRN12618000879268
Suspended
Phase 2Phase 3
The Torpido2 Study: Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on developmental Outcome
Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation of premature infants+2 more
University of Sydney1,200 enrolled5 locationsACTRN12615000115538
Recruiting
Phase 2Phase 3
The To2rpido Study: Targeted Oxygenation in the Resuscitation of Premature Infants and their Developmental Outcome
Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation in premature infants+1 more
The Royal Hospital for Women1,892 enrolled1 locationACTRN12610001059055
Recruiting
Phase 3
The use of probiotics to reduce the incidence of sepsis in premature infants.
Late onset sepsis in very premature infants (<32 weeks)
The Royal Women's Foundation Ltd1,100 enrolled1 locationACTRN12607000144415
Completed
Phase 3
Transfer of preterm infants from incubator to open cot at a lower body weight (1600g) versus a higher body weight (1800g)
Premature infants
Division of neonatology, Royal Brisbane & Women's Hospital180 enrolled1 locationACTRN12606000518561